Management of Contact Dermatitis in Atopic Individuals

Arzu FERHATOSMANOĞLUa , Deniz AKSU ARICAa

aKaradeniz Technical University Faculty of Medicine, Department of Dermatology, Trabzon, Türkiye

Ferhatosmanoğlu A, Aksu Arıca D. Management of contact dermatitis in atopic individuals. In: Günaştı Topal S, ed. Contact Dermatitis. 1st ed. Ankara: Türkiye Klinikleri; 2024. p.60-5.

ABSTRACT

Contact dermatitis is a skin inflammation that can develop due to contact with various substances and significantly affects the quality of life of affected individuals. The prevalence of contact dermatitis in atopic individuals remains unclear due to conflicting data. Although their immunopathogenesis is different, the epidermal barrier impairment in atopic dermatitis and increased exposure to topical products make patients more susceptible to contact dermatitis. The presence of contact dermatitis in atopic dermatitis may exacerbate epidermal barrier dysfunction and increase the severity of the disease. Therefore, it is essential to be aware that contact dermatitis may develop in cases of atopic dermatitis, and understanding its management is crucial. In this article, the management of contact dermatitis in atopic individuals is summarized.

Keywords: Dermatitis, atopic; dermatitis, contact; dermatitis, allergic contact; dermatitis, irritant

Referanslar

  1. Clark SC, Zirwas MJ. Management of occupational dermatitis. Dermatol Clin. 2009;27(3):365-83, vii-viii. [Crossref]
  2. Thyssen JP, Johansen JD, Linneberg A, Menné T. The epidemiology of hand eczema in the general population--prevalence and main findings. Contact Dermatitis. 2010;62(2):75-87. [Crossref]
  3. Alinaghi F, Bennike NH, Egeberg A, Thyssen JP, Johansen JD. Prevalence of contact allergy in the general population: A systematic review and meta-analysis. Contact Dermatitis. 2019;80(2):77-85. [Crossref]
  4. Neale H, Garza-Mayers AC, Tam I, Yu J. Pediatric allergic contact dermatitis. Part 2: Patch testing series, procedure, and unique scenarios. J Am Acad Dermatol. 2021;84(2):247-55. [Crossref]
  5. Avena-Woods C. Overview of atopic dermatitis. Am J Manag Care. 2017;23(8 Suppl):S115-S123.
  6. Gittler JK, Krueger JG, Guttman-Yassky E. Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis. J Allergy Clin Immunol. 2013;131(2):300-13. [Crossref]
  7. Forkel S, Cevik N, Schill T, Worm M, Mahler V, Weisshaar E, et al. Atopic skin diathesis rather than atopic dermatitis is associated with specific contact allergies. J Dtsch Dermatol Ges. 2021;19(2):231-240. [Crossref]
  8. Choi YJ, Byun JY, Choi YW, Roh JY, Choi HY. Analysis of Positive Patch Test Allergens in Allergic Contact Dermatitis Patients with Atopic Dermatitis. Ann Dermatol. 2023;35(4):303-312. [Crossref]
  9. Qian MF, Li S, Honari G, Sarin KY, Chen JK. Prevalence of allergic contact dermatitis following patch testing in patients with atopic dermatitis: A retrospective United States claims-based study. J Am Acad Dermatol. 2023;88(6):1388-90. [Crossref]
  10. Mora-Fernández V, Mercader Garcia P, Borrego Hernando L, González Pérez R, Córdoba Guijarro S, Giménez Arnau A, et al. Epidemiological, Clinical, and Allergy Profile of Patients With Atopic Dermatitis and Hand Eczema: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC). Actas Dermosifiliogr. 2022;113(3):236-43. English, Spanish. [Crossref]
  11. Ozceker D, Haslak F, Dilek F, Sipahi S, Yucel E, Guler N, Tamay Z. Contact sensitization in children with atopic dermatitis. Allergol Immunopathol (Madr). 2019;47(1):47-51. [Crossref]
  12. Ozceker D, Haslak F, Dilek F, Sipahi S, Yucel E, Guler N, Tamay Z. Contact sensitization in children with atopic dermatitis. Allergol Immunopathol (Madr). 2019 Jan-Feb;47(1):47-51. [Crossref]
  13. Borok J, Matiz C, Goldenberg A, Jacob SE. Contact Dermatitis in Atopic Dermatitis Children-Past, Present, and Future. Clin Rev Allergy Immunol. 2019;56(1):86-98. [Crossref]
  14. Owen JL, Vakharia PP, Silverberg JI. The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis. Am J Clin Dermatol. 2018;19(3):293-302. [Crossref]
  15. Bikowski JB. Hand eczema: diagnosis and management. Cutis. 2008;82(4 Suppl):9-15.
  16. Sheehan MP. Plant Associated Irritant & Allergic Contact Dermatitis (Phytodermatitis). Dermatol Clin. 2020;38(3):389-98. [Crossref]
  17. Schloemer JA, Zirwas MJ, Burkhart CG. Airborne contact dermatitis: common causes in the USA. Int J Dermatol. 2015;54(3):271-4. [Crossref]
  18. Jensen P, Hamann D, Hamann CR, Jellesen MS, Jacob SE, Thyssen JP. Nickel and cobalt release from children's toys purchased in Denmark and the United States. Dermatitis. 2014;25(6):356-65. [Crossref]
  19. Jensen P, Johansen JD, Zachariae C, Menné T, Thyssen JP. Excessive nickel release from mobile phones--a persistent cause of nickel allergy and dermatitis. Contact Dermatitis. 2011;65(6):354-8. [Crossref]
  20. Jacob SE, Admani S. iPad--increasing nickel exposure in children. Pediatrics. 2014;134(2):e580-2. [Crossref]
  21. Thyssen JP, Skare L, Lundgren L, Menné T, Johansen JD, Maibach HI, Lidén C. Sensitivity and specificity of the nickel spot (dimethylglyoxime) test. Contact Dermatitis. 2010;62(5):279-88. [Crossref]
  22. Suneja T, Flanagan KH, Glaser DA. Blue-jean button nickel: prevalence and prevention of its release from buttons. Dermatitis. 2007;18(4):208-11. [Crossref]
  23. van Ketel WG, Bruynzeel DP. Chelating effect of EDTA on nickel. Contact Dermatitis. 1984;11(5):311-4. [Crossref]
  24. Wöhrl S, Kriechbaumer N, Hemmer W, Focke M, Brannath W, Götz M, et al. A cream containing the chelator DTPA (diethylenetriaminepenta-acetic acid) can prevent contact allergic reactions to metals. Contact Dermatitis. 2001;44(4):224-8. [Crossref]
  25. Madsen JT, Andersen KE. Further evidence of the methylisothiazolinone epidemic. Contact Dermatitis. 2014;70(4):246-7. [Crossref]
  26. Loranger C, Alfalah M, Ferrier Le Bouedec MC, Sasseville D. Alkyl Glucosides in Contact Dermatitis. Dermatitis. 2017;28(1):5-13. [Crossref]
  27. Fonacier L, Bernstein DI, Pacheco K, Holness DL, Blessing-Moore J, Khan D, et al.; American Academy of Allergy, Asthma & Immunology; American College of Allergy, Asthma & Immunology; Joint Council of Allergy, Asthma & Immunology. Contact dermatitis: a practice parameter-update 2015. J Allergy Clin Immunol Pract. 2015;3(3 Suppl):S1-39. [Crossref]
  28. Fonacier L, Bernstein DI, Pacheco K, Holness DL, Blessing-Moore J, Khan D, et al.; American Academy of Allergy, Asthma & Immunology; American College of Allergy, Asthma & Immunology; Joint Council of Allergy, Asthma & Immunology. Contact dermatitis: a practice parameter-update 2015. J Allergy Clin Immunol Pract. 2015;3(3 Suppl):S1-39. [Crossref]
  29. Bauer A, Schmitt J, Bennett C, Coenraads PJ, Elsner P, English J, et al.. Interventions for preventing occupational irritant hand dermatitis. Cochrane Database Syst Rev. 2010;(6):CD004414. Update in: Cochrane Database Syst Rev. 2018;4:CD004414. [Crossref]
  30. Bourke J, Coulson I, English J; British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of contact dermatitis: an update. Br J Dermatol. 2009160(5):946-54. [Crossref]
  31. Williams C, Wilkinson SM, McShane P, Lewis J, Pennington D, Pierce S, et al. A double-blind, randomized study to assess the effectiveness of different moisturizers in preventing dermatitis induced by hand washing to simulate healthcare use. Br J Dermatol. 2010;162(5):1088-92. [Crossref]
  32. Grandolfo M, Vena GA, Angelini G, Bianchi B. Mometasone furoate versus betamethasone vale-rate in the treatment of allergic contact dermatitis. J Eur Acad Dermatol Venereol. 1999;12(2):178-80. [Crossref]
  33. Hachem JP, De Paepe K, Vanpée E, Bogaerts M, Kaufman L, Rogiers V, et al. Efficacy of topical corticosteroids in nickel-induced contact allergy. Clin Exp Dermatol. 2002;27(1):47-50. [Crossref]
  34. Bhardwaj SS, Jaimes JP, Liu A, Warshaw EM. A double-blind randomized placebo-controlled pilot study comparing topical immunomodulating agents and corticosteroids for treatment of experimentally induced nickel contact dermatitis. Dermatitis. 2007;18(1):26-31. [Crossref]
  35. Katsarou A, Makris M, Papagiannaki K, Lagogianni E, Tagka A, Kalogeromitros D. Tacrolimus 0.1% vs mometasone furoate topical treatment in allergic contact hand eczema: a prospective randomized clinical study. Eur J Dermatol. 2012;22(2):192-6. [Crossref]
  36. Broeders JA, Ahmed Ali U, Fischer G. Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience. J Am Acad Dermatol. 2016;75(2):410-419.e3. [Crossref]
  37. Belsito D, Wilson DC, Warshaw E, Fowler J, Ehrlich A, Anderson B, et al. A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis. J Am Acad Dermatol. 2006;55(1):40-6. [Crossref]
  38. Mose KF, Andersen F, Røpke MA, Skov L, Friedmann PS, Andersen KE. Anti-inflammatory potency testing of topical corticosteroids and calcineurin inhibitors in human volunteers sensitized to diphenylcyclopropenone. Br J Clin Pharmacol. 2018;84(8):1719-28. [Crossref]
  39. Dickel, H. Management of contact dermatitis. Allergo J Int. 2023; 32: 57-76. [Crossref]
  40. Queille-Roussel C, Graeber M, Thurston M, Lachapelle JM, Decroix J, de Cuyper C, et al. SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge. Contact Dermatitis. 2000;42(6):349-50. [Crossref]
  41. Schliemann S, Kelterer D, Bauer A, John SM, Skudlik C, Schindera I, et al. Tacrolimus ointment in the treatment of occupationally induced chronic hand dermatitis. Contact Dermatitis. 2008;58(5):299-306. [Crossref]
  42. Schempp CM, Müller H, Czech W, Schöpf E, Simon JC. Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. J Am Acad Dermatol. 1997;36(5 Pt 1):733-7. [Crossref]
  43. van Coevorden AM, Kamphof WG, van Sonderen E, Bruynzeel DP, Coenraads PJ. Comparison of oral psoralen-UV-A with a portable tanning unit at home vs hospital-administered bath psoralen-UV-A in patients with chronic hand eczema: an open-label randomized controlled trial of efficacy. Arch Dermatol. 2004;140(12):1463-6. [Crossref]
  44. Sezer E, Etikan I. Local narrowband UVB phototherapy vs. local PUVA in the treatment of chronic hand eczema. Photodermatol Photoimmunol Photomed. 2007;23(1):10-4. [Crossref]
  45. Jensen L, Stensgaard A, Andersen KE. Psoralen plus ultraviolet A (PUVA) soaks and UVB TL01 treatment for chronic hand dermatoses. Dermatol Reports. 2012;4(1):e3. [Crossref]
  46. Sung CT, McGowan MA, Machler BC, Jacob SE. Systemic Treatments for Allergic Contact Dermatitis. Dermatitis. 2019;30(1):46-53. [Crossref]
  47. Ludriksone L, Antonov D, Schliemann S, Elsner P. Therapy of allergic and irritant contact dermatitis. In: Johansen JD, Mahler V, Lepoittevin JP, Frosch PJ, eds. Contact Dermatitis. Cham: Springer Nature; 2021. p.1273-97. [Crossref]
  48. Berthold E, Weisshaar E. Therapie des Handekzems [Treatment of hand eczema]. Hautarzt. 2019;70(10):790-6. German. [Crossref]
  49. Granlund H, Erkko P, Reitamo S. Comparison of the influence of cyclosporine and topical betamethasone-17,21-dipropionate treatment on quality of life in chronic hand eczema. Acta Derm Venereol. 1997;77(1):54-8. [Crossref]
  50. So JK, Hamstra A, Calame A, Hamann CR, Jacob SE. Another great imitator: allergic contact dermatitis differential diagnosis, clues to diagnosis, histopathology, and treatment. Current Treatment Options in Allergy. 2015; 2(4):333-48. [Crossref]